Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors

L Fiedler, Lukas Motloch (Erstautor/-in), Anna Maria Dieplinger (Erstautor/-in), Peter Jirak (Co-Autor/-in), P Davtyan, D Gareeva, E Badykova, M Badykov, I Lakman, A Agapitov, L Sadikova, V Pavlov, F Fottinger, Moritz Mirna (Co-Autor/-in), Kristen Kopp (Co-Autor/-in), Uta Hoppe (Co-Autor/-in), R Pistulli, BZ Cai, BF Yang, N Zagidullin